[Clindamycin as adjuvant therapy in Staphilococcal skin scalded syndrome]
- PMID: 25567401
- DOI: 10.4321/s1137-66272014000300017
[Clindamycin as adjuvant therapy in Staphilococcal skin scalded syndrome]
Abstract
Staphylococcal scalded skin syndrome (SSSS) is a dermatologic disease caused by exotoxins produced by Staphylococcus aureus. The disease presents as a painful cutaneous rash that culminates with the detachment of the superficial dermis. The usual treatment is antibiotics with beta-lactamase resistant penicillin. We report the case of a patient who presented with SSSS with initial torpid evolution despite antibiotic treatment and after the introduction of clindamycin IV experienced a very significant improvement. Concerns about the increase of methicillin resistant Staphylococcus aureus (MRSA) and the pathophysiology of this disease make bacteriostatic spectrum antistaphylococcal antibiotics, such as clindamycin, strong candidates for consideration as a first-line therapeutic arsenal for the treatment of SSSS.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical